<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01847261</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #12-226</org_study_id>
    <nct_id>NCT01847261</nct_id>
  </id_info>
  <brief_title>Effects of Protein Blends on Muscle Protein Synthesis in Healthy Older Adults</brief_title>
  <official_title>A Randomized, Controlled Double Blind Acute Study: Effects of Protein Blends on Muscle Protein Synthesis and Breakdown in Healthy Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DuPont Nutrition and Health</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DuPont Nutrition and Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During aging there is a tendency for muscle protein synthesis (growth) to become less
      efficient and the resulting consequence leads to reduced muscle mass (sarcopenia) which can
      affect strength and mobility. Protein consumption may be one opportunity to alleviate this
      problem especially when consumed in appropriate amounts following resistance training. This
      study is designed to determine if a soy dairy protein blend, shown to be effective in younger
      adults, will produce beneficial muscle protein synthesis in older healthy adults following
      resistance exercise.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional Synthetic Rate (Muscle Protein Synthesis)</measure>
    <time_frame>baseline, 3 hrs, 5 hrs</time_frame>
    <description>The fractional synthesis rate (FSR) of mixed muscle proteins will be calculated from the incorporation rate of L-[ring-13C6]Phenylalanine into the mixed muscle proteins, and the free-tissue phenylalanine enrichment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anti-inflammatory and Anti-oxidant Markers</measure>
    <time_frame>baseline, 3 hrs, 5 hrs</time_frame>
    <description>Proteins will be assessed that are markers of oxidative damage and inflammation (NFkB, IL-1, IL-6) and proteolysis (MuRF, MAFBx).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracellular Signalling Genes and Proteins</measure>
    <time_frame>baseline, 3 hrs, 5 hrs</time_frame>
    <description>Phosphorylation of Mammalian Target of Rapamycin (mTOR) pathway will be measured using Western blot techniques</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Muscle Synthesis</condition>
  <arm_group>
    <arm_group_label>Soy Dairy Protein Blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 grams of Soy Dairy Protein Blend given as a single beverage following leg resistance exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Positive Control (Dairy Whey Protein)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 grams of Dairy Whey Protein will be given as a single beverage following leg resistance exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soy Dairy Protein Blend</intervention_name>
    <arm_group_label>Soy Dairy Protein Blend</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Positive Control (Dairy Whey Protein)</intervention_name>
    <arm_group_label>Positive Control (Dairy Whey Protein)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        55-70 yr olds Stable Body weight

        Exclusion Criteria:

          1. Exercise training (&gt;2 weekly sessions of moderate to high intensity aerobic or
             resistance exercise)

          2. Significant heart, liver, kidney, blood, respiratory disease or thyroid issues

          3. Peripheral vascular disease

          4. Orthopedic injury that prohibits participation in the exercise training

          5. Diabetes mellitus or other untreated endocrine disease

          6. Active cancer (all groups) and history of cancer

          7. Acute infectious disease or history of chronic infections (e.g. TB, hepatitis, HIV,
             herpes)

          8. Neurologic Injury or disease

          9. Recent (within 6 months) treatment with anabolic steroids, or corticosteroids.

         10. Alcohol or drug abuse

         11. Tobacco use (smoking or chewing)

         12. Malnutrition (BMI &lt; 20 kg/m2, hypoalbuminemia, and/or hypotransferrinemia)

         13. Obesity (BMI &gt; 30 kg/m2)

         14. Low hemoglobin levels (below normal values)

         15. Food allergies

         16. Taking dietary supplements such as green tea, omega 3 fatty acids, etc.

         17. Females
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Blake Rasmussen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>April 24, 2013</study_first_submitted>
  <study_first_submitted_qc>May 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2013</study_first_posted>
  <last_update_submitted>October 3, 2019</last_update_submitted>
  <last_update_submitted_qc>October 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>soy</keyword>
  <keyword>whey</keyword>
  <keyword>muscle</keyword>
  <keyword>older</keyword>
  <keyword>mTOR</keyword>
  <keyword>sarcopenia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

